The emerging role of the sigma-1 receptor in autophagy: hand-in-hand targets for the treatment of Alzheimer’s

References

• Martin WR, Eades CG, Thompson J, et al. The effects of morphine-and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog. J Pharmacol Exp Ther. 1976;197(3):517–532.
   PubMed Web of Science ®Google Scholar
• Su T-P. Evidence for sigma opioid receptor: binding of [3H] SKF-10047 to etorphine-inaccessible sites in guinea-pig brain. J Pharmacol Exp Ther. 1982;223(2):284–290.
   PubMed Web of Science ®Google Scholar
• Hellewell SB, Bowen WD. A sigma-like binding site in rat pheochromocytoma (PC12) cells: decreased affinity for (+)-benzomorphans and lower molecular weight suggest a different sigma receptor form from that of guinea pig brain. Brain Res. 1990;527(2):244–253.
   PubMed Web of Science ®Google Scholar
• Quirion R, Bowen WD, Itzhak Y, et al. A proposal for the classification of sigma binding sites. Trends Pharmacol Sci. 1992;13:85–86.
   PubMed Web of Science ®Google Scholar
• Abbas H, Borde P, Willars GB, et al. Hazards of Using Masking Protocols When Performing Ligand Binding Assays: lessons From the Sigma-1 and Sigma-2 Receptors. Front Pharmacol. 2020;11:309.
   PubMed Web of Science ®Google Scholar
• Hanner M, Moebius FFFF, Flandorfer A, et al. Purification, molecular cloning and expression of the mammalian sigma1-binding site. Proc Nat Acad Sci. 1996;93(15):8072. .
   PubMed Web of Science ®Google Scholar
• Kekuda R, Prasad PDPD, Fei Y-JY-J, et al. Cloning and Functional Expression of the Human Type 1 Sigma Receptor (hSigmaR1)*. Biochem Biophys Res Commun. 1996;229(2):553–558. .
   PubMed Web of Science ®Google Scholar
• Seth P, Leibach FH, Ganapathy V. Cloning and structural analysis of the cDNA and the gene encoding the murine type 1 sigma receptor. Biochem Biophys Res Commun. 1997;241(2):535–540.
   PubMed Web of Science ®Google Scholar
• Schmidt HR, Zheng S, Gurpinar E, et al. Crystal structure of the human σ1 receptor. Nature. 2016;532(7600):527. .
   PubMed Web of Science ®Google Scholar
• Schmidt HR, Betz RM, Dror RO, et al. Structural basis for σ 1 receptor ligand recognition. Nat Struct Mol Biol. 2018;25(10):981.
   PubMed Web of Science ®Google Scholar
• Mishra AK, Mavlyutov T, Singh DR, et al. The sigma-1 receptors are present in monomeric and oligomeric forms in living cells in the presence and absence of ligands. Biochem J. 2015;466(2):263–271. .
   PubMed Web of Science ®Google Scholar
• Hong WC. Distinct Regulation of σ1 Receptor Multimerization by Its Agonists and Antagonists in Transfected Cells and Rat Liver Membranes. J Pharmacol Exp Ther. 2020;373(2):290–301.
   PubMed Web of Science ®Google Scholar
• Brimson JM, Brimson S, Chomchoei C, et al. Using Sigma-ligands as part of a multi-receptor approach to target diseases of the brain. In: Expert opinion on therapeutic targets; 2020;24(10):1009-1028.
   Google Scholar
• Prince M, Guerchet M, Prina M. The global impact of dementia 2013-2050. Alzheimer’s disease international; 2013.
   Google Scholar
• Gauthier S, Cummings J, Ballard C, et al. Management of behavioral problems in Alzheimer’s disease. Int Psychogeriatr. 2010;22(3):346. .
   PubMed Web of Science ®Google Scholar
• Giri M, Zhang M, Lü Y. Genes associated with Alzheimer’s disease: an overview and current status. Clin Interv Aging. 2016;11:665.
   PubMed Web of Science ®Google Scholar
• Jorm AF. Alzheimer’s disease: risk and protection. Med J Aust. 1997;167(8):443–446.
   PubMed Web of Science ®Google Scholar
• Troussière A-C, Charley CM, Salleron J, et al. Treatment of sleep apnoea syndrome decreases cognitive decline in patients with Alzheimer’s disease. J Neurol Neurosurg. 2014;85(12):1405–1408. .
   Web of Science ®Google Scholar
• Benedict C, Byberg L, Cedernaes J, et al. Self-reported sleep disturbance is associated with Alzheimer’s disease risk in men. Alzheimers Dement. 2015;11(9):1090–1097. .
   PubMed Web of Science ®Google Scholar
• Solfrizzi V, Panza F, Frisardi V, et al. Diet and Alzheimer’s disease risk factors or prevention: the current evidence. Expert Rev Neurother. 2011;11(5):677–708. .
   PubMed Web of Science ®Google Scholar
• Christ MG, Huesmann H, Nagel H, et al. Sigma-1 receptor activation induces autophagy and increases proteostasis capacity in vitro and in vivo. Cells. 8(3): 211. 2019. .
   PubMed Web of Science ®Google Scholar
• Li J-R, Xu H-Z, Nie S, et al. Fluoxetine-enhanced autophagy ameliorates early brain injury via inhibition of NLRP3 inflammasome activation following subarachnoid hemorrhage in rats. J Neuroinflammation. 2017;14(1):1–14. .
   PubMedGoogle Scholar
• Shu X, Sun Y, Sun X, et al. The effect of fluoxetine on astrocyte autophagy flux and injured mitochondria clearance in a mouse model of depression. Cell Death Dis. 2019;10(8):1–16. .
   Google Scholar
• Cho YS, Yen C-N, Shim JS, et al. Antidepressant indatraline induces autophagy and inhibits restenosis via suppression of mTOR/S6 kinase signaling pathway. Sci Rep. 2016;6(1):34655. .
   PubMed Web of Science ®Google Scholar
• Klionsky DJ. Autophagy. Curr Biol. 2005;15(8):R282–R283.
   PubMed Web of Science ®Google Scholar
• Tanida I, Ueno T, Kominami E. LC3 and Autophagy. In: Autophagosome and phagosome. Springer; 2008. p. 77–88
   Google Scholar
• Klionsky DJ, Abdel-Aziz AK, Abdelfatah S, et al. Guidelines for the use and interpretation of assays for monitoring autophagy. autophagy. 2021;17(1):1–382.
   PubMed Web of Science ®Google Scholar
• Klionsky DJ. Look people, “Atg” is an abbreviation for “autophagy-related”. That’s it. Autophagy 2012;8(9):1281–1282.
   PubMed Web of Science ®Google Scholar
• Lamb CA, Yoshimori T, Tooze SA. The autophagosome: origins unknown, biogenesis complex. Nat Rev Mol Cell Biol. 2013;14(12):759–774.
   PubMed Web of Science ®Google Scholar
• Chan EY. Regulation and function of uncoordinated-51 like kinase proteins. Antioxid Redox Signal. 2012;17(5):775–785.
   PubMed Web of Science ®Google Scholar
• Di Bartolomeo S, Corazzari M, Nazio F, et al. The dynamic interaction of AMBRA1 with the dynein motor complex regulates mammalian autophagy. J Cell Biol. 2010;191(1):155–168. .
   PubMed Web of Science ®Google Scholar
• Komatsu M, Wang QJ, Holstein GR, et al. Essential role for autophagy protein Atg7 in the maintenance of axonal homeostasis and the prevention of axonal degeneration. Proc Nat Acad Sci. 2007;104(36):14489–14494. .
   PubMed Web of Science ®Google Scholar
• Komatsu M, Waguri S, Chiba T, et al. Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature. 2006;441(7095):880–884. .
   PubMed Web of Science ®Google Scholar
• Hara T, Nakamura K, Matsui M, et al. Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature. 2006;441(7095):885–889. .
   PubMed Web of Science ®Google Scholar
• Nixon RA, Wegiel J, Kumar A, et al. Extensive involvement of autophagy in Alzheimer disease: an immuno-electron microscopy study. J Neuropathol Exp Neurol. 2005;64(2):113–122. .
   PubMed Web of Science ®Google Scholar
• Boland B, Kumar A, Lee S, et al. Autophagy induction and autophagosome clearance in neurons: relationship to autophagic pathology in Alzheimer’s disease. J Neurosci. 2008;28(27):6926–6937. .
   PubMed Web of Science ®Google Scholar
• Lee J-H, Yu WH, Kumar A, et al. Lysosomal proteolysis and autophagy require presenilin 1 and are disrupted by Alzheimer-related PS1 mutations. Cell. 2010;141(7):1146–1158. .
   PubMed Web of Science ®Google Scholar
• Xie Y, Kang R, Tang D. Role of the Beclin 1 Network in the Cross-Regulation between Autophagy and Apoptosis. In: Autophagy: cancer, Other Pathologies, Inflammation, Immunity, Infection, and Aging. Academic PressElsevier; 2016. p. 75–88.
   Google Scholar
• Pickford F, Masliah E, Britschgi M, et al. The autophagy-related protein beclin 1 shows reduced expression in early Alzheimer disease and regulates amyloid β accumulation in mice. J Clin Invest. 2008;118(6):2190–2199. .
   PubMed Web of Science ®Google Scholar
• Small SA, Kent K, Pierce A, et al. Model‐guided microarray implicates the retromer complex in Alzheimer’s disease. Ann Neurol. 2005;58(6):909–919. .
   PubMed Web of Science ®Google Scholar
• Berger Z, Davies JE, Luo S, et al. Deleterious and protective properties of an aggregate-prone protein with a polyalanine expansion. Hum Mol Genet. 2006;15(3):453–465. .
   PubMed Web of Science ®Google Scholar
• Krüger U, Wang Y, Kumar S, et al. Autophagic degradation of tau in primary neurons and its enhancement by trehalose. Neurobiol Aging. 2012;33(10):2291–2305. .
   PubMed Web of Science ®Google Scholar
• Luna-Munoz J, Chavez-Macias L, Garcia-Sierra F, et al. Earliest Stages of Tau Conformational Changes are Related to the Appearance of a Sequence of Specific Phospho-Dependent Tau Epitopes in Alzheimer’s Disease 1. J Alzheimers Dis. 2007;12(4):365–375. .
   PubMed Web of Science ®Google Scholar
• Frake RA, Ricketts T, Menzies FM, et al. Autophagy and neurodegeneration. J Clin Invest. 2015;125(1):65–74. .
   PubMed Web of Science ®Google Scholar
• Rahman MA, Rahman MS, Rahman MH, et al. Promising modulatory effects of autophagy on APP processing as a potential treatment for Alzheimer’s disease. 2020.
   Google Scholar
• Murphy MP. How mitochondria produce reactive oxygen species. Biochem J. 2009;417(1):1–13.
   PubMed Web of Science ®Google Scholar
• Salminen A, Kaarniranta K, Kauppinen A, et al. Impaired autophagy and APP processing in Alzheimer’s disease: the potential role of Beclin 1 interactome. Prog Neurobiol. 2013;106:33–54.
   PubMed Web of Science ®Google Scholar
• Li L, Zhang X, Le W. Autophagy dysfunction in Alzheimer’s disease. Neurodegen Dis. 2010;7(4):265–271.
   PubMed Web of Science ®Google Scholar
• Son SM, Song H, Byun J, et al. Accumulation of autophagosomes contributes to enhanced amyloidogenic APP processing under insulin-resistant conditions. Autophagy. 2012;8(12):1842–1844. .
   PubMed Web of Science ®Google Scholar
• Joshi G, Gan KA, Johnson DA, et al. Increased Alzheimer’s disease–like pathology in the APP/PS1ΔE9 mouse model lacking Nrf2 through modulation of autophagy. Neurobiol Aging. 2015;36(2):664–679. .
   PubMed Web of Science ®Google Scholar
• Zare-Shahabadi A, Masliah E, Johnson GV, et al. Autophagy in Alzheimer’s disease. Rev Neurosci. 2015;26(4):385–395. .
   PubMed Web of Science ®Google Scholar
• Funderburk SF, Marcellino BK, Yue Z. Cell “self‐eating”(autophagy) mechanism in Alzheimer’s disease. Mt Sinai J Med. 2010;77(1):59–68.
   PubMedGoogle Scholar
• Yang D-S, Kumar A, Stavrides P, et al. Neuronal apoptosis and autophagy cross talk in aging PS/APP mice, a model of Alzheimer’s disease. Am J Pathol. 2008;173(3):665–681. .
   PubMed Web of Science ®Google Scholar
• Hamasaki M, Furuta N, Matsuda A, et al. Autophagosomes form at ER–mitochondria contact sites. Nature. 2013;495(7441):389–393. .
   PubMed Web of Science ®Google Scholar
• Yang H, Shen H, Li J, et al. Sigma-1 receptor ablation impairs autophagosome clearance. Autophagy. 2019;14.
   Google Scholar
• Mizushima N, Levine B. Autophagy in mammalian development and differentiation. Nat Cell Biol. 2010;12(9):823–830.
   PubMed Web of Science ®Google Scholar
• Langa F, Codony X, Tovar V, et al. Generation and phenotypic analysis of sigma receptor type I (σ1) knockout mice. Eur J Neurosci. 2003;18(8):2188–2196. .
   PubMed Web of Science ®Google Scholar
• Sabino V, Cottone P, Parylak SL, et al. Sigma-1 receptor knockout mice display a depressive-like phenotype. Behav Brain Res. 2009;198(2):472–476. .
   PubMed Web of Science ®Google Scholar
• Korpis K, Weber F, Brune S, et al. Involvement of apoptosis and autophagy in the death of RPMI 8226 multiple myeloma cells by two enantiomeric sigma receptor ligands. Bioorg Med Chem. 2014;22(1):221–233. .
   PubMed Web of Science ®Google Scholar
• Schrock JM, Spino CM, Longen CG, et al. Sequential Cytoprotective Responses to Sigma1 Ligand–Induced Endoplasmic Reticulum Stress. Mol Pharmacol. 2013;84(5):751–762. .
   PubMed Web of Science ®Google Scholar
• Hindmarch I, Hashimoto K. Cognition and depression: the effects of fluvoxamine, a sigma‐1 receptor agonist, reconsidered. Hum Psychopharmacol Clin Exp. 2010;25(3):193–200.
   PubMed Web of Science ®Google Scholar
• Robson MJ, Elliott M, Seminerio MJ, et al. Evaluation of sigma (σ) receptors in the antidepressant-like effects of ketamine in vitro and in vivo. Eur Neuropsychopharmacol. 2012;22(4):308–317. .
   PubMed Web of Science ®Google Scholar
• Tatsumi M, Groshan K, Blakely RD, et al. Pharmacological profile of antidepressants and related compounds at human monoamine transporters. Eur J Pharmacol. 1997;340(2–3):249–258. .
   PubMed Web of Science ®Google Scholar
• Jeon S-H, Kim SH, Kim Y, et al. The tricyclic antidepressant imipramine induces autophagic cell death in U-87MG glioma cells. Biochem Biophys Res Commun. 2011;413(2):311–317. .
   PubMed Web of Science ®Google Scholar
• Ordoñez R, Fernández A, Prieto‐Domínguez N, et al. Ceramide metabolism regulates autophagy and apoptotic cell death induced by melatonin in liver cancer cells. J Pineal Res. 2015;59(2):178–189. .
   PubMed Web of Science ®Google Scholar
• Rossi M, Munarriz ER, Bartesaghi S, et al. Desmethylclomipramine induces the accumulation of autophagy markers by blocking autophagic flux. J Cell Sci. 2009;122(18):3330–3339. .
   PubMed Web of Science ®Google Scholar
• Su T-P, Hayashi T, Maurice T, et al. The sigma-1 receptor chaperone as an inter-organelle signaling modulator. Trends Pharmacol Sci. 2010;31(12):557–566. .
   PubMed Web of Science ®Google Scholar
• Bolshakova AV, Kukanova EO, Gainullina AN, et al. Sigma-1 receptor as a potential pharmacological target for the treatment of neuropathology. St Petersburg Polytech Univ J. 2016;2(1):31–40. .
   Google Scholar
• Wang X, Li Y, Deuther-Conrad W, et al. Synthesis and biological evaluation of 18F labeled fluoro-oligo-ethoxylated 4-benzylpiperazine derivatives for sigma-1 receptor imaging. Bioorg Med Chem. 2013;21(1):215–222. .
   PubMed Web of Science ®Google Scholar
• Toyohara J, Sakata M, Ishiwata K. Re-evaluation of in vivo selectivity of [11C] SA4503 to σ1 receptors in the brain: contributions of emopamil binding protein. Nucl Med Biol. 2012;39(7):1049–1052.
   PubMed Web of Science ®Google Scholar
• Wang I-F, Tsai K-J, Shen C-KJ. Autophagy activation ameliorates neuronal pathogenesis of FTLD-U mice: a new light for treatment of TARDBP/TDP-43 proteinopathies. Autophagy. 2013;9(2):239–240.
   PubMed Web of Science ®Google Scholar
• Kaverina NV, Kadagidze ZG, Borovjagin AV, et al. Tamoxifen overrides autophagy inhibition in Beclin-1-deficient glioma cells and their resistance to adenovirus-mediated oncolysis via upregulation of PUMA and BAX. Oncogene. 2018;37(46):6069–6082. .
   PubMed Web of Science ®Google Scholar
• Cho KS, Yoon YH, Choi JA, et al. Induction of autophagy and cell death by tamoxifen in cultured retinal pigment epithelial and photoreceptor cells. Invest Ophthalmol Vis Sci. 2012;53(9):5344–5353. .
   PubMed Web of Science ®Google Scholar
• Torres‐López L, Maycotte P, Liñán‐Rico A, et al. Tamoxifen induces toxicity, causes autophagy, and partially reverses dexamethasone resistance in Jurkat T cells. J Leukoc Biol. 2019;105(5):983–998. .
   PubMed Web of Science ®Google Scholar
• Graham CD, Kaza N, Klocke BJ, et al. Tamoxifen induces cytotoxic autophagy in glioblastoma. J Neuropathol Exp Neurol. 2016;75(10):946–954. .
   PubMed Web of Science ®Google Scholar
• O’Neill K, Chen S, Brinton RD. Impact of the selective estrogen receptor modulator, tamoxifen, on neuronal outgrowth and survival following toxic insults associated with aging and Alzheimer’s disease. Exp Neurol. 2004;188(2):268–278.
   PubMed Web of Science ®Google Scholar
• Wang X, Wang W, Li L, et al. Oxidative stress and mitochondrial dysfunction in Alzheimer’s disease. Biochim Biophys Acta Mol Basis Dis. 2014;1842(8):1240–1247. .
   PubMed Web of Science ®Google Scholar
• Ghosh Ghosh I, Sankhe R, Mudgal J, et al. Spermidine, an autophagy inducer, as a therapeutic strategy in neurological disorders. Neuropeptides. 2020:102083
   PubMed Web of Science ®Google Scholar
• Rahman MA, Rhim H. Therapeutic implication of autophagy in neurodegenerative diseases. BMB Rep. 2017;50(7):345.
   PubMed Web of Science ®Google Scholar
• Cuervo AM, Bergamini E, Brunk UT, et al. Autophagy and aging: the importance of maintaining” clean” cells. Autophagy. 2005;1(3):131–140. .
   PubMed Web of Science ®Google Scholar
• Hara Y, McKeehan N, Fillit HM. Translating the biology of aging into novel therapeutics for Alzheimer disease. Neurology. 2019;92(2):84–93.
   PubMed Web of Science ®Google Scholar
• Gruendler R, Hippe B, Sendula Jengic V, et al. Nutraceutical Approaches of Autophagy and Neuroinflammation in Alzheimer’s Disease: a Systematic Review. Molecules. 2020;25(24):6018. .
   Web of Science ®Google Scholar
• Rahman MA, Bishayee K, Habib K, et al. 18α-Glycyrrhetinic acid lethality for neuroblastoma cells via de-regulating the Beclin-1/Bcl-2 complex and inducing apoptosis. Biochem Pharmacol. 2016;117:97–112.
   PubMed Web of Science ®Google Scholar
• Rahman MA, Bishayee K, Sadra A, et al. Oxyresveratrol activates parallel apoptotic and autophagic cell death pathways in neuroblastoma cells. Biochim Biophys Acta. 2017;1861(2):23–36. .
   Web of Science ®Google Scholar
• Mputhia Z, Hone E, Tripathi T, et al. Autophagy modulation as a treatment of amyloid diseases. Molecules. 2019;24(18):3372. .
   Web of Science ®Google Scholar
• Congdon EE, Wu JW, Myeku N, et al. Methylthioninium chloride (methylene blue) induces autophagy and attenuates tauopathy in vitro and in vivo. Autophagy. 2012;8(4):609–622. .
   PubMed Web of Science ®Google Scholar
• Di Meco A, Li J-G, Blass BE, et al. 12/15-Lipoxygenase inhibition reverses cognitive impairment, brain amyloidosis, and tau pathology by stimulating autophagy in aged triple transgenic mice. Biol Psychiatry. 2017;81(2):92–100. .
   PubMed Web of Science ®Google Scholar
• Nixon RA. Autophagy, amyloidogenesis and Alzheimer's disease. J Cell Sci. 2007;120(23):4081–4091.
   PubMed Web of Science ®Google Scholar
• Tian Y, Bustos V, Flajolet M, et al. A small‐molecule enhancer of autophagy decreases levels of Aβ and APP‐CTF via Atg5‐dependent autophagy pathway. FASEB J. 2011;25(6):1934–1942. .
   PubMed Web of Science ®Google Scholar
• Li C, Guo X-D, Lei M, et al. Thamnolia vermicularis extract improves learning ability in APP/PS1 transgenic mice by ameliorating both Aβ and Tau pathologies. Acta Pharmacol Sin. 2017;38(1):9–28. .
   PubMed Web of Science ®Google Scholar
• Chow VW, Mattson MP, Wong PC, et al. An overview of APP processing enzymes and products. Neuromolecular Med. 2010;12(1):1–12. .
   PubMed Web of Science ®Google Scholar
• Bekris L, Galloway N, Millard S, et al. Amyloid precursor protein (APP) processing genes and cerebrospinal fluid APP cleavage product levels in Alzheimer’s disease. Neurobiol Aging. 2011;32(3):556.e13–556. e23. .
   PubMed Web of Science ®Google Scholar
• Li F, Chung T, Vierstra RD. AUTOPHAGY-RELATED11 plays a critical role in general autophagy-and senescence-induced mitophagy in Arabidopsis. Plant Cell. 2014;26(2):788–807.
   PubMed Web of Science ®Google Scholar
• Nilsson P, Saido TC. Dual roles for autophagy: degradation and secretion of Alzheimer’s disease Aβ peptide. Bioessays. 2014;36(6):570–578.
   PubMed Web of Science ®Google Scholar
• O’Keefe L, Denton D. Using Drosophila models of amyloid toxicity to study autophagy in the pathogenesis of Alzheimer’s disease. Biomed Res Int. 2018;2018:2018.
   Web of Science ®Google Scholar
• Wen J, Fang F, Guo S-H, et al. Amyloid β-derived diffusible ligands (ADDLs) induce abnormal autophagy associated with Aβ aggregation degree. J Mol Neurosci. 2018;64(2):162–174. .
   PubMed Web of Science ®Google Scholar
• Liu J, Li L. Targeting Autophagy for the Treatment of Alzheimer’s Disease: challenges and Opportunities. Front Mol Neurosci. 2019;12:203.
   PubMed Web of Science ®Google Scholar
• Harold D, Abraham R, Hollingworth P, et al. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer’s disease. Nat Genet. 2009;41(10):1088–1093. .
   PubMed Web of Science ®Google Scholar
• Kok E, Haikonen S, Luoto T, et al. Apolipoprotein E–dependent accumulation of Alzheimer disease–related lesions begins in middle age. Ann Neurol. 2009;65(6):650–657. .
   PubMed Web of Science ®Google Scholar
• Parcon PA, Balasubramaniam M, Ayyadevara S, et al. Apolipoprotein E4 inhibits autophagy gene products through direct, specific binding to CLEAR motifs. Alzheimers Dement. 2018;14(2):230–242. .
   PubMed Web of Science ®Google Scholar
• Gundlach AL, Largent BL, Snyder SH. Autoradiographic localization of sigma receptor binding sites in guinea pig and rat central nervous system with (+) 3H-3-(3-hydroxyphenyl)-N-(1-propyl) piperidine. J Neurosci. 1986;6(6):1757–1770.
   PubMed Web of Science ®Google Scholar
• Sánchez-Fernández C, Entrena JM, Baeyens JM, et al. Sigma-1 receptor antagonists: a new class of neuromodulatory analgesics. In: Sigma Receptors: their Role in Disease and as Therapeutic Targets: springer. 2017. p. 109–132.
   Google Scholar
• Su T-P, Hayashi T. Understanding the molecular mechanism of sigma-1 receptors: towards a hypothesis that sigma-1 receptors are intracellular amplifiers for signal transduction. Curr Med Chem. 2003;10(20):2073–2080.
   PubMed Web of Science ®Google Scholar
• De B, Nadal X, Portillo-salido E, et al. Sigma-1 receptors regulate activity-induced spinal sensitization and neuropathic pain after peripheral nerve injury. Pain. 2009;145(3):294–303. .
   PubMed Web of Science ®Google Scholar
• Nieto FR, Cendán CM, Sánchez-Fernández C, et al. Role of sigma-1 receptors in paclitaxel-induced neuropathic pain in mice. J Pain. 2012;13(11):1107–1121. .
   PubMed Web of Science ®Google Scholar
• Zamanillo D, Romero L, Merlos M, et al. Sigma 1 receptor: a new therapeutic target for pain. Eur J Pharmacol. 2013;716(1–3):78–93. .
   PubMed Web of Science ®Google Scholar
• Brimson JM, Safrany ST, Qassam H, et al. Dipentylammonium Binds to the Sigma-1 Receptor and Protects Against Glutamate Toxicity, Attenuates Dopamine Toxicity and Potentiates Neurite Outgrowth in Various Cultured Cell Lines. Neurotox Res. 2018;34(2):263–272. .
   PubMed Web of Science ®Google Scholar
• Villard V, Espallergues J, Keller E, et al. Anti-amnesic and neuroprotective potentials of the mixed muscarinic receptor/sigma1 (σ1) ligand ANAVEX2-73, a novel aminotetrahydrofuran derivative. J Psychopharmacol. 2011;25(8):1101–1117. .
   PubMed Web of Science ®Google Scholar
• Frecska E, Szabo A, Winkelman MJ, et al. A possibly sigma-1 receptor mediated role of dimethyltryptamine in tissue protection, regeneration, and immunity. J Neural Transm. 2013;120(9):1295–1303. .
   PubMed Web of Science ®Google Scholar
• Pal A, Fontanilla D, Gopalakrishnan A, et al. The sigma-1 receptor protects against cellular oxidative stress and activates antioxidant response elements. Eur J Pharmacol. 2012;682(1–3):12–20. .
   PubMed Web of Science ®Google Scholar
• Hayashi T, Tsai S-YS-Y, Mori T, et al. Targeting ligand-operated chaperone sigma-1 receptors in the treatment of neuropsychiatric disorders. Expert Opinion Ther Targets. 2011;15(5):557–577. .
   PubMed Web of Science ®Google Scholar
• Ishima T, Fujita Y, Hashimoto K. Interaction of new antidepressants with sigma-1 receptor chaperones and their potentiation of neurite outgrowth in PC12 cells. Eur J Pharmacol. 2014;727:167–173.
   PubMed Web of Science ®Google Scholar
• Nishimura T, Ishima T, Iyo M, et al. Potentiation of nerve growth factor-induced neurite outgrowth by fluvoxamine: role of sigma-1 receptors, IP3 receptors and cellular signaling pathways. PLoS One. 2008;3(7):e2558–e2558. .
   PubMed Web of Science ®Google Scholar
• Ishima T, Hashimoto K. Potentiation of nerve growth factor-induced neurite outgrowth in PC12 cells by ifenprodil: the role of sigma-1 and IP3 receptors. PloS One. 2012;7(5):e37989–e37989.
   PubMed Web of Science ®Google Scholar
• Kawamura K, Kimura Y, Tsukada H, et al. An increase of sigma1 receptors in the aged monkey brain. Neurobiol Aging. 24(5): 745–752. 2003. .
   PubMed Web of Science ®Google Scholar
• Wallace DR, Mactutus CF, Booze RM. Sigma binding sites identified by [3H] DTG are elevated in aged Fischer‐344× Brown Norway (F1) rats. Synapse. 2000;35(4):311–313. .
   PubMed Web of Science ®Google Scholar
• Horsager J, Fedorova TD, Berge NV, et al. Cardiac 11C-Donepezil Binding Increases With Age in Healthy Humans: potentially Signifying Sigma-1 Receptor Upregulation. J Cardiovasc Pharmacol Ther. 24(4): 365–370. 2019. .
   PubMed Web of Science ®Google Scholar
• Norbury R, Travis MJ, Erlandsson K, et al. In vivo imaging of muscarinic receptors in the aging female brain with (R, R)[123I]-I-QNB and single photon emission tomography. Exp Gerontol. 2005;40(3):137–145. .
   PubMed Web of Science ®Google Scholar
• Inoue M, Suhara T, Sudo Y, et al. Age-related reduction of extrastriatal dopamine D2 receptor measured by PET. Life Sci. 2001;69(9):1079–1084. .
   PubMed Web of Science ®Google Scholar
• Sheline YI, Mintun MA, Moerlein SM, et al. Greater loss of 5-HT2A receptors in midlife than in late life. Am J Psychiatry. 2002;159(3):430–435. .
   PubMed Web of Science ®Google Scholar
• Mishina M, Ohyama M, Ishii K, et al. Low density of sigma 1 receptors in early Alzheimer’s disease. Ann Nucl Med. 22(3): 151. 2008. .
   PubMed Web of Science ®Google Scholar
• Cataldo AM, Barnett JL, Berman SA, et al. Gene expression and cellular content of cathepsin D in Alzheimer’s disease brain: evidence for early up-regulation of the endosomal-lysosomal system. Neuron. 1995;14(3):671–680. .
   PubMed Web of Science ®Google Scholar
• Barnett A, Brewer GJ. Autophagy in aging and Alzheimer’s disease: pathologic or protective? J Alzheimers Dis. 2011;25(3):385–394.
   PubMed Web of Science ®Google Scholar
• Holmes C, Boche D, Wilkinson D, et al. Long-term effects of Aβ42 immunisation in Alzheimer’s disease: follow-up of a randomised, placebo-controlled phase I trial. Lancet. 2008;372(9634):216–223. .
   PubMed Web of Science ®Google Scholar
• Lacor PN, Buniel MC, Furlow PW, et al. Aβ oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer’s disease. J Neurosci. 2007;27(4):796–807. .
   PubMed Web of Science ®Google Scholar
• Games D, Adams D, Alessandrini R, et al. Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein. Nature. 1995;373(6514):523–527. .
   PubMed Web of Science ®Google Scholar
• Pannuzzo M. On the physiological/pathological link between Aβ peptide, cholesterol, calcium ions and membrane deformation: a molecular dynamics study. Biochimi Biophys Acta (BBA) Biomembr. 2016;1858(6):1380–1389.
   PubMed Web of Science ®Google Scholar
• Hayashi T, Su T-P. Sigma-1 Receptor Chaperones at the ER- Mitochondrion Interface Regulate Ca 2 + Signaling and Cell Survival. Cell. 2007;131(3):596–610.
   PubMed Web of Science ®Google Scholar
• Wu Z, Bowen WD. Role of Sigma-1 Receptor C-terminal Segment in Inositol 1, 4, 5-Trisphosphate Receptor Activation. J Biol Chem. 2008;283(42):28198–28215.
   PubMed Web of Science ®Google Scholar
• Csordás G, Renken C, Várnai P, et al. Structural and functional features and significance of the physical linkage between ER and mitochondria. J Cell Biol. 2006;174(7):915–921.
   PubMed Web of Science ®Google Scholar
• Hayashi T. Sigma-1 receptor: the novel intracellular target of neuropsychotherapeutic drugs. J Pharmacol Sci. 2015;127(1):2–5.
   PubMed Web of Science ®Google Scholar
• Antonini V, Marrazzo A, Kleiner G, et al. Anti-amnesic and neuroprotective actions of the sigma-1 receptor agonist (-)-MR22 in rats with selective cholinergic lesion and amyloid infusion. J Alzheimers Dis. 2011;24(3):569–586. .
   PubMed Web of Science ®Google Scholar
• Maurice T. Protection by sigma-1 receptor agonists is synergic with donepezil, but not with memantine, in a mouse model of amyloid-induced memory impairments. Behav Brain Res. 2016;296:270–278.
   PubMed Web of Science ®Google Scholar
• Hall H, Iulita MF, Gubert P, et al. AF710B, an M1/sigma-1 receptor agonist with long-lasting disease-modifying properties in a transgenic rat model of Alzheimer’s disease. Alzheimer’s Dementia. 2018;14(6):811–823. .
   PubMed Web of Science ®Google Scholar
• Kametani F, Hasegawa M. Reconsideration of amyloid hypothesis and tau hypothesis in Alzheimer’s disease. Front Neurosci. 2018;12:25.
   PubMed Web of Science ®Google Scholar
• Mohandas E, Rajmohan V, Raghunath B. Neurobiology of Alzheimer’s disease. Indian J Psychiatry. 2009;51(1):55.
   PubMedGoogle Scholar
• Cleveland DW, Hwo S-Y, Kirschner MW. Purification of tau, a microtubule-associated protein that induces assembly of microtubules from purified tubulin. J Mol Biol. 1977;116(2):207–225.
   PubMed Web of Science ®Google Scholar
• Tsai S-YA, Pokrass MJ, Klauer NR, et al. Sigma-1 receptor regulates Tau phosphorylation and axon extension by shaping p35 turnover via myristic acid. Proc Nat Acad Sci. 2015;112(21):6742–6747. .
   PubMed Web of Science ®Google Scholar
• Caccamo A, Oddo S, Billings LM, et al. M1 receptors play a central role in modulating AD-like pathology in transgenic mice. Neuron. 2006;49(5):671–682. .
   PubMed Web of Science ®Google Scholar
• Hayashi T, Fujimoto M. Detergent-resistant microdomains determine the localization of σ-1 receptors to the endoplasmic reticulum-mitochondria junction. Mol Pharmacol. 2010;77(4):517–528.
   PubMed Web of Science ®Google Scholar
• Palmer CP, Mahen R, Schnell E, et al. Sigma-1 receptors bind cholesterol and remodel lipid rafts in breast cancer cell lines. Cancer Res. 2007;67(23):11166–11175. .
   PubMed Web of Science ®Google Scholar
• Hayashi T, Su TP. The potential role of sigma-1 receptors in lipid transport and lipid raft reconstitution in the brain: implication for drug abuse. Life Sci. 2005;77(14):1612–1624.
   PubMed Web of Science ®Google Scholar
• Hayashi T, Su T-P. σ-1 Receptors (σ1 binding sites) form raft-like microdomains and target lipid droplets on the endoplasmic reticulum: roles in endoplasmic reticulum lipid compartmentalization and export. J Pharmacol Exp Ther. 2003;306(2):718–725.
   PubMed Web of Science ®Google Scholar
• Pabba M, Wong AY, Ahlskog N, et al. NMDA receptors are upregulated and trafficked to the plasma membrane after sigma-1 receptor activation in the rat hippocampus. J Neurosci. 2014;34(34):11325–11338. .
   PubMed Web of Science ®Google Scholar
• Hayashi T, Su T-P. Sigma-1 receptors at galactosylceramide-enriched lipid microdomains regulate oligodendrocyte differentiation. Proc Nat Acad Sci. 2004;101(41):14949–14954.
   PubMed Web of Science ®Google Scholar
• Ruscher K, Shamloo M, Rickhag M, et al. The sigma-1 receptor enhances brain plasticity and functional recovery after experimental stroke. Brain. 2011;134(3):732–746. .
   PubMedGoogle Scholar
• Takebayashi M, Hayashi T, Su TP. σ‐1 Receptors potentiate epidermal growth factor signaling towards neuritogenesis in PC12 cells: potential relation to lipid raft reconstitution. Synapse. 2004;53(2):90–103.
   PubMed Web of Science ®Google Scholar
• Lahmy V, Meunier J, Malmström S, et al. Blockade of Tau hyperphosphorylation and Aβ 1–42 generation by the aminotetrahydrofuran derivative ANAVEX2-73, a mixed muscarinic and σ 1 receptor agonist, in a nontransgenic mouse model of Alzheimer’s disease. Neuropsychopharmacology. 2013;38(9):1706. .
   PubMed Web of Science ®Google Scholar
• Nguyen PTH, Kimura T, Ho SA, et al. Ameliorative effects of a neuroprotective agent, T‐817MA, on place learning deficits induced by continuous infusion of amyloid‐β peptide (1–40) in rats. Hippocampus. 2007;17(6):443–455. .
   PubMed Web of Science ®Google Scholar
• Molander‐Melin M, Blennow K, Bogdanovic N, et al. Structural membrane alterations in Alzheimer brains found to be associated with regional disease development; increased density of gangliosides GM1 and GM2 and loss of cholesterol in detergent‐resistant membrane domains. J Neurochem. 2005;92(1):171–182. .
   PubMed Web of Science ®Google Scholar
• Pernber Z, Blennow K, Bogdanovic N, et al. Altered distribution of the gangliosides GM1 and GM2 in Alzheimer’s disease. Dement Geriatr Cogn Disord. 2012;33(2–3):174–188. .
   PubMed Web of Science ®Google Scholar
• Jaeger PA, Pickford F, Sun C-H, et al. Regulation of amyloid precursor protein processing by the Beclin 1 complex. PloS One. 2010;5(6):e11102. .
   PubMed Web of Science ®Google Scholar
• Kim J, Basak JM, Holtzman DM. The role of apolipoprotein E in Alzheimer’s disease. Neuron. 2009;63(3):287–303.
   PubMed Web of Science ®Google Scholar
• Huang Y, Zheng L, Halliday G, et al. Genetic polymorphisms in sigma-1 receptor and apolipoprotein E interact to influence the severity of Alzheimer’s disease. Curr Alzheimer Res. 2011;8(7):765–770. .
   PubMed Web of Science ®Google Scholar
• Hayashi T, Su TP. The sigma receptor: evolution of the concept in neuropsychopharmacology. Curr Neuropharmacol. 2005;3(4):267–280.
   PubMedGoogle Scholar
• Farlow MR, Salloway S, Tariot PN, et al. Effectiveness and tolerability of high-dose (23 mg/d) versus standard-dose (10 mg/d) donepezil in moderate to severe Alzheimer’s disease: a 24-week, randomized, double-blind study. Clin Ther. 2010 Jul;32(7):1234–1251. .
   PubMed Web of Science ®Google Scholar
• Jia J, Wei C, Jia L, et al. Efficacy and Safety of Donepezil in Chinese Patients with Severe Alzheimer’s Disease: a Randomized Controlled Trial. J Alzheimers Dis. 2017;56(4):1495–1504. .
   PubMed Web of Science ®Google Scholar
• Rogers SL, Friedhoff LT. The efficacy and safety of donepezil in patients with Alzheimer’s disease: results of a US Multicentre, Randomized, Double-Blind, Placebo-Controlled Trial. The Donepezil Study Group. Dementia 1996 Nov-Dec;7(6):293–303. .
   PubMedGoogle Scholar
• Tariot PN, Cummings JL, Katz IR, et al. A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer’s disease in the nursing home setting. J Am Geriatr Soc. 2001 Dec;49(12):1590–1599. .
   PubMed Web of Science ®Google Scholar
• Swedish Council on Health Technology A. SBU Systematic Reviews. Dementia – caring, Ethics, Ethnical and Economical Aspects: a Systematic Review. Stockholm: Swedish Council on Health Technology Assessment (SBU). Copyright © 2008 by the Swedish Council on Health Technology Assessment; 2008.
   Google Scholar
• Ramakrishnan NK, Visser AK, Schepers M, et al. Dose-dependent sigma-1 receptor occupancy by donepezil in rat brain can be assessed with 11 C-SA4503 and microPET. Psychopharmacology (Berl). 2014;231(20):3997–4006. .
   PubMed Web of Science ®Google Scholar
• Ishima T, Nishimura T, Iyo M, et al. Potentiation of nerve growth factor-induced neurite outgrowth in PC12 cells by donepezil: role of sigma-1 receptors and IP3 receptors. Prog Neuro Psychopharmacol Biol Psychiatry. 2008;32(7):1656–1659. .
   PubMed Web of Science ®Google Scholar
• Solntseva E, Kapai N, Popova O, et al. The involvement of sigma1 receptors in donepezil-induced rescue of hippocampal LTP impaired by beta-amyloid peptide. Brain Res Bull. 2014;106:56–61.
   PubMed Web of Science ®Google Scholar
• Inagaki S, Funato M, Nakamura S, et al. Donepezil, an anti-Alzheimer’s disease drug has the neuroprotective effect on RGCs derived from familial glaucoma patients’ iPS cells. Invest Ophthalmol Vis Sci. 2019;60(9):626.
   Web of Science ®Google Scholar
• Kim E, Park M, Jeong J, et al. Cholinesterase inhibitor donepezil increases mitochondrial biogenesis through AMP-activated protein kinase in the hippocampus. Neuropsychobiology. 2016;73(2):81–91. .
   PubMed Web of Science ®Google Scholar
• Lahmy V, Long R, Morin D, et al. Mitochondrial protection by the mixed muscarinic/σ1 ligand ANAVEX2-73, a tetrahydrofuran derivative, in Aβ25–35 peptide-injected mice, a nontransgenic Alzheimer’s disease model. Front Cell Neurosci. 2015;8:463.
   PubMed Web of Science ®Google Scholar
• Macfarlane S, Cecchi M, Moore D, et al. New Exploratory Alzheimer’s Drug ANAVEX 2-73 Changes in Electrophysiological Markers in Alzheimer’s Disease-First Patient Data from an ongoing Phase 2a Study in mild-to-moderate Alzheimer’s Patients. Clin Neuropharmacol. 2002;25(4):207–215. .
   PubMedGoogle Scholar
• Garnock-Jones KP. Dextromethorphan/Quinidine. CNS Drugs. 2011;25(5):435–445.
   PubMed Web of Science ®Google Scholar
• Chou Y-C, Liao J-F, Chang W-Y, et al. Binding of dimemorfan to sigma-1 receptor and its anticonvulsant and locomotor effects in mice, compared with dextromethorphan and dextrorphan. Brain Res. 1999;821(2):516–519. .
   PubMed Web of Science ®Google Scholar
• Nguyen L, Robson MJ, Healy JR, et al. Involvement of sigma-1 receptors in the antidepressant-like effects of dextromethorphan. PloS One. 2014;9(2):e89985. .
   PubMed Web of Science ®Google Scholar
• Cummings JL, Lyketsos CG, Peskind ER, et al. Effect of dextromethorphan-quinidine on agitation in patients with Alzheimer's disease dementia: a randomized clinical trial. Jama. 2015;314(12):1242–1254. .
   PubMed Web of Science ®Google Scholar
• Fukushima T, Koide M, Ago Y, et al. T-817MA, a novel neurotrophic agent, improves sodium nitroprusside-induced mitochondrial dysfunction in cortical neurons. Neurochem Int. 2006;48(2):124–130. .
   PubMed Web of Science ®Google Scholar
• Kimura T, Hong Nguyen PT, Ho SA, et al. T‐817MA, a neurotrophic agent, ameliorates the deficits in adult neurogenesis and spatial memory in rats infused icv with amyloid‐β peptide. Br J Pharmacol. 2009;157(3):451–463. .
   PubMed Web of Science ®Google Scholar
• Fukushima T, Nakamura A, Iwakami N, et al. T-817MA, a neuroprotective agent, attenuates the motor and cognitive impairments associated with neuronal degeneration in P301L tau transgenic mice. Biochem Biophys Res Commun. 2011;407(4):730–734. .
   PubMed Web of Science ®Google Scholar
• Schneider LS, Thomas RG, Hendrix S, et al. Safety and efficacy of edonerpic maleate for patients with mild to moderate Alzheimer's disease: a phase 2 randomized clinical trial. JAMA Neurol. 2019;76(11):1330–1339. .
   PubMed Web of Science ®Google Scholar
• Pandey D, Banerjee S, Basu M, et al. Memory enhancement by Tamoxifen on amyloidosis mouse model. Horm Behav. 2016;79:70–73.
   PubMed Web of Science ®Google Scholar
• Karimi S, Hejazian SH, Alikhani V, et al. The effects of tamoxifen on spatial and nonspatial learning and memory impairments induced by scopolamine and the brain tissues oxidative damage in ovariectomized rats. Adv Biomed Res. 2015;4:4.
   PubMedGoogle Scholar
• Zabihi H, Hosseini M, Pourganji M, et al. The effects of tamoxifen on learning, memory and brain tissues oxidative damage in ovariectomized and naive female rats. Adv Biomed Res. 2014;3:3.
   PubMedGoogle Scholar
• Maurice T. Bi-phasic dose response in the preclinical and clinical developments of sigma-1 receptor ligands for the treatment of neurodegenerative disorders. In: Expert Opinion on Drug Discovery. 2020. p. 1–17.
   Google Scholar
• Breuer B, Anderson R. The relationship of tamoxifen with dementia, depression, and dependence in activities of daily living in elderly nursing home residents. Women Health. 2000;31(1):71–85.
   PubMed Web of Science ®Google Scholar
• Sun L-M, Chen H-J, Liang J-A, et al. Long-term use of tamoxifen reduces the risk of dementia: a nationwide population-based cohort study. QJM. 2015;109(2):103–109. .
   PubMed Web of Science ®Google Scholar
• Bromley SE, Matthews A, Smeeth L, et al. Risk of dementia among postmenopausal breast cancer survivors treated with aromatase inhibitors versus tamoxifen: a cohort study using primary care data from the UK. J Cancer Survivorship. 2019;13(4):632–640. .
   PubMed Web of Science ®Google Scholar
• Nguyen L, Lucke-Wold BP, Mookerjee SA, et al. Role of sigma-1 receptors in neurodegenerative diseases. J Pharmacol Sci. 2015;127(1):17–29. .
   PubMed Web of Science ®Google Scholar
• Moriguchi S, Shinoda Y, Yamamoto Y, et al. Stimulation of the sigma-1 receptor by DHEA enhances synaptic efficacy and neurogenesis in the hippocampal dentate gyrus of olfactory bulbectomized mice. PloS One. 2013;8(4):e60863–e60863. .
   PubMed Web of Science ®Google Scholar
• Rosen DA, Seki SM, Fernández-Castañeda A, et al. Modulation of the sigma-1 receptor–IRE1 pathway is beneficial in preclinical models of inflammation and sepsis. Sci Transl Med. 2019;11(478):eaau5266. .
   PubMed Web of Science ®Google Scholar
• Maurice T, Volle J-N, Strehaiano M, et al. Neuroprotection in non-transgenic and transgenic mouse models of Alzheimer’s disease by positive modulation of σ1 receptors. Pharmacol Res. 2019;144:315–330.
   PubMed Web of Science ®Google Scholar
• Zvejniece L, Vavers E, Svalbe B, et al. The cognition‐enhancing activity of E1R, a novel positive allosteric modulator of sigma‐1 receptors. Br J Pharmacol. 2014;171(3):761–771. .
   PubMed Web of Science ®Google Scholar
• Guo L, Chen Y, Zhao R, et al. Allosteric modulation of sigma‐1 receptors elicits anti‐seizure activities. Br J Pharmacol. 2015;172(16):4052–4065. .
   PubMed Web of Science ®Google Scholar
• Rubinsztein David C, Mariño G, Kroemer G. Autophagy and Aging. Cell. 2011;146(5):682–695.
   PubMed Web of Science ®Google Scholar